SCHEMBL17827464

SCHEMBL17827464

c1ccc(-c2ccc(N(c3ccc(-c4ccc(-c5cccc(C6(c7ccccc7)c7ccccc7-c7ccccc76)c5)cc4)cc3)c3ccc4c(c3)oc3ccccc34)cc2)cc1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP12 P39900 1/20 0.33
MMP13 P45452 1/20 0.33
PLA2G2A P14555 3/20 0.33
PLA2G4A P47712 3/20 0.33
AHR P35869 2/20 0.33
ALOX5 P09917 1/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 2/20 0.32
MAPT P10636 2/20 0.32
KMT2A Q03164 2/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
PLA2G10 O15496 1/20 0.31
PDK2 Q15119 1/20 0.31
LMNA P02545 1/20 0.31
OPRK1 P41145 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17827459 1.00 MMP12 (0.33) MMP12MMP13PLA2G2APLA2G4AAHR
SCHEMBL17827475 1.00 MMP12 (0.33) MMP12MMP13PLA2G2APLA2G4AAHR
SCHEMBL17827454 1.00 MMP12 (0.33) MMP12MMP13PLA2G2APLA2G4AAHR
SCHEMBL17827438 0.96 PLA2G2A (0.35) MMP12MMP13PLA2G2APLA2G4AAHR
SCHEMBL22134217 0.96 AHR (0.33) MMP12MMP13PLA2G2APLA2G4AAHR
SCHEMBL22403479 0.95 AHR (0.32) MMP12MMP13PLA2G2APLA2G4AAHR
SCHEMBL22403541 0.95 AHR (0.32) MMP12MMP13PLA2G2APLA2G4AAHR
SCHEMBL22403659 0.95 AHR (0.32) MMP12MMP13PLA2G2APLA2G4AAHR
SCHEMBL21039290 0.94 PDK2 (0.32) KDM4EMEN1MAPTKMT2APDK2
SCHEMBL17827462 0.94 CA12 (0.35) MMP12MMP13

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9929355-B2 Amine compound and organic electroluminescent device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-27 US disclosed
US-9929355-B2 Amine compound and organic electroluminescent device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-27 US disclosed
US-20160172593-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-16 US disclosed
US-20160172593-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2016-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160172593-A1 AMINE COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE INCLUDING THE SAME AOC2, SAT1, ODC1 MMP12 4517/4885MMP13 4789/4885PLA2G2A 3891/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.